InvenireX secures £2m in seed funding led by DSW Ventures to accelerate DNA nanotechology detection

InvenireX develops programmable DNA nanotechnology for ultra-sensitive disease detection, combining nanoscale structures, microfluidics and AI to identify genetic markers far earlier than existing methods.